Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients ; volume:310 ; number:4 ; day:2 ; month:8 ; year:2024 ; pages:2183-2190 ; date:10.2024
Archives of gynecology and obstetrics ; 310, Heft 4 (2.8.2024), 2183-2190, 10.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Attianese, Daniela
Massobrio, Roberta
Giorgi, Margherita
Villa, Michela
Fuso, Luca
Badellino, Enrico
Bellero, Marco
Ferrero, Annamaria
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00404-024-07670-4
- URN
-
urn:nbn:de:101:1-2411262123115.917122146365
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Attianese, Daniela
- Massobrio, Roberta
- Giorgi, Margherita
- Villa, Michela
- Fuso, Luca
- Badellino, Enrico
- Bellero, Marco
- Ferrero, Annamaria
- SpringerLink (Online service)
Ähnliche Objekte (12)
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
Therapeutic options in heavily pretreated HIV-1 patients based on the genotypic resistance patterns
Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem